Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study

被引：1

作者：

Pils, Marlene ^{[1
,2
]}

Dybala, Alexandra ^{[3
]}

Schaffrath, Anja ^{[1
]}

Rehn, Fabian ^{[1
,2
]}

Kutzsche, Janine ^{[1
]}

Bloemeke, Lara ^{[1
]}

Tusche, Markus ^{[1
]}

Oezduezenciler, Pelin ^{[1
]}

Bujnicki, Tuyen ^{[1
]}

Kraemer-Schulien, Victoria ^{[1
]}

Gramespacher, Hannes ^{[4
]}

Schmieschek, Maximilian H. T. ^{[4
]}

Barbe, Michael T. ^{[4
]}

Onur, Oezguer A. ^{[4
,5
]}

Fink, Gereon R. ^{[4
,5
]}

Tamguney, Gultekin ^{[1
,3
]}

Bannach, Oliver ^{[1
,2
]}

Willbold, Dieter ^{[1
,2
,3
]}

机构：

[1] Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, D-52428 Julich, Germany

[2] attyloid GmbH, D-40225 Dusseldorf, Germany

[3] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany

[4] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Neurol, D-50937 Cologne, Germany

[5] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, D-52428 Julich, Germany

来源：

ALZHEIMERS RESEARCH & THERAPY | 2024年 / 16卷 / 01期

关键词：

Amyloidosis; A beta oligomer quantitation; sFIDA; Brain-gut-microbiota axis; Leaky gut; Fecal/stool samples; Clearance; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; GUT-MICROBIOTA; DIAGNOSIS; BRAIN;

D O I：

10.1186/s13195-024-01597-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

BackgroundMisfolding and aggregation of amyloid beta (A beta), along with neurofibrillary tangles consisting of aggregated Tau species, are pathological hallmarks of Alzheimer's disease (AD) onset and progression. In this study, we hypothesized the clearance of A beta aggregates from the brain and body into the gut.MethodsTo investigate this, we used surface-based fluorescence intensity distribution analysis (sFIDA) to determine the A beta aggregate concentrations in feces from 26 AD patients and 31 healthy controls (HC).ResultsA beta aggregates were detectable in human feces and their concentrations were elevated in AD patients compared to HC (specificity 90.3%, sensitivity 53.8%).ConclusionThus, fecal A beta aggregates constitute a non-invasive biomarker candidate for diagnosing AD. Whether digestion-resistant A beta aggregates in feces are secreted via the liver and bile or directly from the enteric neuronal system remains to be elucidated.

引用

页数：15

共 50 条

[21] Classification of Patients with Alzheimer's Disease and Dementia with Lewy Bodies using Resting EEG Selected Features at Sensor and Source Levels: A Proof-of-Concept Study
San-Martin, Rodrigo
Fraga, Francisco J.
Del Percio, Claudio
Lizio, Roberta
Noce, Giuseppe
Nobili, Flavio
Arnaldi, Dario
D'Antonio, Fabrizia
De Lena, Carlo
Guntekin, Bahar
Hanoglu, Lutfu
Taylor, John Paul
McKeith, Ian
Stocchi, Fabrizio
Ferri, Raffaele
Onofrj, Marco
Lopez, Susanna
Bonanni, Laura
Babiloni, Claudio
CURRENT ALZHEIMER RESEARCH, 2021, 18 (12) : 956 - 969
[22] Impulsivity traits and awareness of motor intention in Parkinson’s disease: a proof-of-concept study
Fabio Giovannelli
Chiara Menichetti
Lorenzo Kiferle
Laura Maria Raglione
Stefania Brotini
Paola Vanni
Duccio Bacci
Mariella Baldini
Alessandra Borgheresi
Alessandra Del Bene
Enrico Grassi
Leonello Guidi
Lucia Toscani
Gino Volpi
Pasquale Palumbo
Maria Pia Viggiano
Massimo Cincotta
Neurological Sciences, 2022, 43 : 335 - 340
[23] Baduanjin Qigong Intervention by Telerehabilitation (TeleParkinson): A Proof-of-Concept Study in Parkinson's Disease
Carvalho, Livia P.
Decary, Simon
Beaulieu-Boire, Isabelle
Dostie, Rosalie
Lalonde, Isabelle
Texier, Emilie
Laprise, Laurence
Pepin, Elizabeth
Gilbert, Melodie
Corriveau, Helene
Tousignant, Michel
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
[24] Impulsivity traits and awareness of motor intention in Parkinson's disease: a proof-of-concept study
Giovannelli, Fabio
Menichetti, Chiara
Kiferle, Lorenzo
Raglione, Laura Maria
Brotini, Stefania
Vanni, Paola
Bacci, Duccio
Baldini, Mariella
Borgheresi, Alessandra
Del Bene, Alessandra
Grassi, Enrico
Guidi, Leonello
Toscani, Lucia
Volpi, Gino
Palumbo, Pasquale
Viggiano, Maria Pia
Cincotta, Massimo
NEUROLOGICAL SCIENCES, 2022, 43 (01) : 335 - 340
[25] An Attachment-Based Intervention for Patients With Cardiovascular Disease and Their Partners: A Proof-of-Concept Study
Tulloch, Heather
Johnson, Susan
Demidenko, Natasha
Clyde, Matthew
Bouchard, Karen
Greenman, Paul S.
HEALTH PSYCHOLOGY, 2021, 40 (12) : 909 - 919
[26] RNAi: From Concept to Human Proof-of-Concept
Vaishnaw, Akshay
Nochur, Sara
Ftizgerlad, Kevin
Simon, Amy
Gollob, Jared
NUCLEIC ACID THERAPEUTICS, 2012, 22 (06) : A12 - A12
[27] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
Jeffrey L. Cummings
Kate Zhong
Jefferson W. Kinney
Chelcie Heaney
Joanne Moll-Tudla
Abhinay Joshi
Michael Pontecorvo
Michael Devous
Anne Tang
James Bena
Alzheimer's Research & Therapy, 8
[28] The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy
Rodriguez-Ruiz, Emelina R.
Herrero-Labrador, Raquel
Fernandez-Fernandez, Ana P.
Serrano-Masa, Julia
Martinez-Montero, Jose A.
Gonzalez-Nieto, Daniel
Hana-Vaish, Mayuri
Benchekroun, Mohamed
Ismaili, Lhassane
Marco-Contelles, Jose
Martinez-Murillo, Ricardo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
[29] Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study
Todberg, Tanja
Skov, Lone
Simonsen, Stine
Kainu, Kati
Zachariae, Claus
ACTA DERMATO-VENEREOLOGICA, 2020, 100
[30] Just a Small, Proof-of-Concept Study
Novack, Gary D.
OCULAR SURFACE, 2009, 7 (02): : 111 - 112

← 1 2 3 4 5 →